![Vaccines | Free Full-Text | COVID-19 Vaccines and Hyperglycemia—Is There a Need for Postvaccination Surveillance? Vaccines | Free Full-Text | COVID-19 Vaccines and Hyperglycemia—Is There a Need for Postvaccination Surveillance?](https://www.mdpi.com/vaccines/vaccines-10-00454/article_deploy/html/images/vaccines-10-00454-g001.png)
Vaccines | Free Full-Text | COVID-19 Vaccines and Hyperglycemia—Is There a Need for Postvaccination Surveillance?
![Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021–January 2022: A retrospective, population-based, matched cohort study - eClinicalMedicine Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021–January 2022: A retrospective, population-based, matched cohort study - eClinicalMedicine](https://www.thelancet.com/cms/asset/a260c5f5-8e9c-449f-a91c-fb7caf88b74d/gr1.jpg)
Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021–January 2022: A retrospective, population-based, matched cohort study - eClinicalMedicine
![Biology | Free Full-Text | Environmental Factors and the Risk of Developing Type 1 Diabetes—Old Disease and New Data Biology | Free Full-Text | Environmental Factors and the Risk of Developing Type 1 Diabetes—Old Disease and New Data](https://pub.mdpi-res.com/biology/biology-11-00608/article_deploy/html/images/biology-11-00608-g001-550.jpg?1650097921)
Biology | Free Full-Text | Environmental Factors and the Risk of Developing Type 1 Diabetes—Old Disease and New Data
![Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_749053_16849082873589850.jpg)
Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients
![Type 1 diabetes left out of Covid-19 conversation, but ripple effects are ongoing - Pharmaceutical Technology Type 1 diabetes left out of Covid-19 conversation, but ripple effects are ongoing - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2021/05/type-1-diabetes.jpg)
Type 1 diabetes left out of Covid-19 conversation, but ripple effects are ongoing - Pharmaceutical Technology
![Frontiers | Omicron Variant of SARS-CoV-2 Virus: In Silico Evaluation of the Possible Impact on People Affected by Diabetes Mellitus Frontiers | Omicron Variant of SARS-CoV-2 Virus: In Silico Evaluation of the Possible Impact on People Affected by Diabetes Mellitus](https://www.frontiersin.org/files/Articles/847993/fendo-13-847993-HTML/image_m/fendo-13-847993-g001.jpg)
Frontiers | Omicron Variant of SARS-CoV-2 Virus: In Silico Evaluation of the Possible Impact on People Affected by Diabetes Mellitus
![COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022 | MMWR COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7112e2_HospitalizationsVaccineStatus_IMAGE_18March22_1200x675.jpg?_=67057)
COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022 | MMWR
![SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study - The Lancet Diabetes & Endocrinology SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/27be58b9-5bbe-4ad6-adef-bfa8bb40a4fb/gr1.jpg)